SAMHD1 limits the efficacy of forodesine in leukaemia by protecting cells against cytotoxicity of dGTP

Warning

There is a more recent version of this eprint available. Click here to view it.

This is a preprint and may not have undergone formal peer review

Metadata

Item Type:	Preprint
Authors/Creators:	Davenne, T Klintman, J Sharma, S Rigby, R.E Cursi, C Bridgeman, A Dadonaite, B De Keersmaecker, K Hillmen, P https://orcid.org/0000-0001-5617-4403 Chabes, A Schuh, A Rehwinkel, J
Dates:	Published: 17 February 2020
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Haematology and Immunology
Depositing User:	Symplectic Publications
Date Deposited:	08 Nov 2024 15:48
Last Modified:	08 Nov 2024 15:55
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:157488

Available Versions of this Item

SAMHD1 limits the efficacy of forodesine in leukaemia by protecting cells against cytotoxicity of dGTP. (deposited 08 Nov 2024 15:48) [Currently Displayed]
- SAMHD1 Limits the Efficacy of Forodesine in Leukemia by Protecting Cells against the Cytotoxicity of dGTP. (deposited 08 Nov 2024 15:44)

CORE (COnnecting REpositories)

CORE (COnnecting REpositories)